ArticleMolecular oncology2023

Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapy.

Hai-Yan Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.